NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY.

VIEWPOINT. Leading mRNA Biomedical and mRNA Biotech Companies

1 minute (overview).

Industry Reference Data (Public Info)

TICKER    MARKET CAP    LINK

  1. MRNA     $48 Billion       Moderna, Inc. 
  2. BNTX      $32 Billion        BioNTech SE
  3. ALNY      $24 Billion        Alnylam Pharmaceuticals, Inc.
  4. SRPT      $9.8 Billion        Sarepta Therapeutics, Inc. 
  5. IONS      $6.4 Billion        Ionis Pharmaceuticals, Inc. 
  6. ARWR    $3.5 Billion        Arrowhead Pharmaceuticals, Inc. 
  7. CVAC      $1.4 Billion        CureVac N.V. 
  8. ARCT     $390 million      Arcturus Therapeutics Holdings Inc. 

Private Companies: (source: GEN News)

  1. Abogen Biosciences $817 million
  2. Laronde $490 million
  3. Normax Biomed $300 million
  4. Sirnaomics $270 million
  5. Deep Genomics $236 million
  6. Nutcracker Therapeutic  $219 million
  7. VaxEquity $195 million (ICL and AstraZeneca)
  8. eTheRNA $60 million
  9. DIOSynVax $42 million (Univ. of Cambridge, GOV UK and CEPI)
  10. Ethris $26 million

Big Pharma active in mRNA vaccine R&D

  1. Pfizer
  2. GSK
  3. Novartis
  4. Janssen/Johnson & Johnson
  5. Roche
  6. AstraZeneca
  7. Merck/MSD
  8. Merck KGaA
  9. Sanofi ($3.2 billion acquisition of Translate Bio)
By |2022-11-06T16:00:34+00:00October 23, 2022|Blog Posts|Comments Off on VIEWPOINT. Leading mRNA Biomedical and mRNA Biotech Companies
Go to Top